Retatrutide
Retatrutide is a triple-agonist peptide (GLP-1 + GIP + glucagon) that Phase 3 FDA trials just completed, which is showing some of the strongest weight-loss results ever recorded with a peptide.
Research Use Only.
Research Use Only.
Vial Size
Choose Quantity :
Product Information
Product Details
Who Might Use It in Research?
- Individuals exploring extreme fat loss & appetite control
- Researchers focused on insulin sensitivity & type-2 diabetes reversal
- Those studying next-generation weight-loss compounds
- Anti-aging / longevity protocols
- Performance & body-composition optimization
How Does It Work?
- Reduces appetite, slows digestion, controls blood sugar (GLP-1)
- Improves fat-tissue insulin sensitivity (GIP)
- Boosts metabolism & fat oxidation/burning (Glucagon)
What Researchers Typically Observe?
- Average (Phase 2 - 24%/58 lbs/48 weeks) (Phase 3 - 29%/72lbs/68wks)
- Up to 95% liver-fat reduction
- Significant reduction in osteo-arthritic pain
- Drops in blood sugar, HbA1c drops up to ~2%
- Significant improvements in triglycerides, cholesterol, and blood pressure